318 related articles for article (PubMed ID: 32660285)
1. Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer.
Zhou H; Shen W; Zou H; Lv Q; Shao P
J Int Med Res; 2020 Jul; 48(7):300060520934297. PubMed ID: 32660285
[TBL] [Abstract][Full Text] [Related]
2. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
3. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer.
Hashad D; Elbanna A; Ibrahim A; Khedr G
J Clin Lab Anal; 2016 Nov; 30(6):1100-1105. PubMed ID: 27184562
[TBL] [Abstract][Full Text] [Related]
5. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer.
Zhou X; Yin C; Dang Y; Ye F; Zhang G
Sci Rep; 2015 Jun; 5():11516. PubMed ID: 26096073
[TBL] [Abstract][Full Text] [Related]
6. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.
Wang J; Yang K; Yuan W; Gao Z
Med Sci Monit; 2018 Dec; 24():9307-9316. PubMed ID: 30576305
[TBL] [Abstract][Full Text] [Related]
7. Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer.
Li S; Zhang M; Zhang H; Hu K; Cai C; Wang J; Shi L; Ma P; Xu Y; Zheng P
Clin Chim Acta; 2020 Feb; 501():252-257. PubMed ID: 31730812
[TBL] [Abstract][Full Text] [Related]
8. Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer.
Han P; Zhao J; Gao L
J Clin Lab Anal; 2021 Nov; 35(11):e23979. PubMed ID: 34551140
[TBL] [Abstract][Full Text] [Related]
9. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
10. Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer.
Xu H; Zhou J; Tang J; Min X; Yi T; Zhao J; Ren Y
J Clin Lab Anal; 2020 Aug; 34(8):e23323. PubMed ID: 32274858
[TBL] [Abstract][Full Text] [Related]
11. Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study.
Song Q; Lv X; Ru Y; Dong J; Chang R; Wu D; Chen L; Wang X; Guo X
EBioMedicine; 2022 Apr; 78():103971. PubMed ID: 35349826
[TBL] [Abstract][Full Text] [Related]
12. MiRNA-200c, MiRNA-139 and ln RNA H19; new predictors of treatment response in H-pylori- induced gastric ulcer or progression to gastric cancer.
Schaalan M; Mohamed W; Fathy S
Microb Pathog; 2020 Dec; 149():104442. PubMed ID: 32795593
[TBL] [Abstract][Full Text] [Related]
13. Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer.
Zhao R; Zhang Y; Zhang X; Yang Y; Zheng X; Li X; Liu Y; Zhang Y
Mol Cancer; 2018 Feb; 17(1):68. PubMed ID: 29486794
[TBL] [Abstract][Full Text] [Related]
14. Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer.
Lin LY; Yang L; Zeng Q; Wang L; Chen ML; Zhao ZH; Ye GD; Luo QC; Lv PY; Guo QW; Li BA; Cai JC; Cai WY
Mol Cancer; 2018 Apr; 17(1):84. PubMed ID: 29690888
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis.
Zheng R; Liang J; Lu J; Li S; Zhang G; Wang X; Liu M; Wang W; Chu H; Tao G; Zhao Q; Wang M; Du M; Qiang F; Zhang Z
Gastric Cancer; 2019 Jul; 22(4):731-741. PubMed ID: 30603909
[TBL] [Abstract][Full Text] [Related]
16. Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer.
Min L; Zhu T; Lv B; An T; Zhang Q; Shang Y; Yu Z; Zheng L; Wang Q
Int J Clin Oncol; 2022 Jun; 27(6):1013-1024. PubMed ID: 35482171
[TBL] [Abstract][Full Text] [Related]
17. Plasma Exosomal Long Noncoding RNA lnc-SLC2A12-10:1 as a Novel Diagnostic Biomarker for Gastric Cancer.
Zheng P; Zhang H; Gao H; Sun J; Li J; Zhang X; Gao L; Ma P; Li S
Onco Targets Ther; 2020; 13():4009-4018. PubMed ID: 32494155
[TBL] [Abstract][Full Text] [Related]
18. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer.
Zhang K; Shi H; Xi H; Wu X; Cui J; Gao Y; Liang W; Hu C; Liu Y; Li J; Wang N; Wei B; Chen L
Theranostics; 2017; 7(1):213-227. PubMed ID: 28042329
[TBL] [Abstract][Full Text] [Related]
20. The expression profiling of circulating miR-204, miR-182, and lncRNA H19 as novel potential biomarkers for the progression of peptic ulcer to gastric cancer.
Mohamed WA; Schaalan MF; Ramadan B
J Cell Biochem; 2019 Aug; 120(8):13464-13477. PubMed ID: 30945348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
